India  
 
NewsR.in

Two dozen vaccines under pre-clinical trials in India: Harsh Vardhan

Video Credit: ANI - Duration: 01:08s - Published
Two dozen vaccines under pre-clinical trials in India: Harsh Vardhan

Two dozen vaccines under pre-clinical trials in India: Harsh Vardhan

Union Health Minister Harsh Vardhan along with his wife Nutan Goel took the second shot of Covid vaccine at Delhi Heart and Lung Institute on March 30 and said that many districts are recovering without a single case of COVID-19 within few days.

He said, "There are 430 districts in the country where not a single case of coronavirus has been reported in the last 28 days.

The situation is under control but we don't have to be complacent in terms of observing COVID appropriate behaviour." "Around seven more COVID vaccine candidates are in clinical trials.

Some of them are in the advanced phase of the trials.

Around two dozen vaccines are in pre-clinical trials," he added.


You Might Like


๐Ÿ’ก newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccineโ€™s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research. #IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity ~HT.97~PR.152~

Credit: Oneindia    Duration: 03:29Published

Related videos from verified sources

Riley doctor, Indy mom react to Pfizer COVID-19 vaccine child trial results [Video]

Riley doctor, Indy mom react to Pfizer COVID-19 vaccine child trial results

As Hoosiers age 16 and older were able to register for a COVID-19 vaccine Wednesday morning, Pfizer and BioNTech released its findings from the vaccine trials in children ages 12 to 15-years-old.

Credit: RTV6 The Indy Channel     Duration: 03:08Published
Pfizer Says COVID-19 Vaccine Effective In Adolescents [Video]

Pfizer Says COVID-19 Vaccine Effective In Adolescents

The company says clinical trial results showed 100% efficacy in children ages 12 to 15.

Credit: CBS 3 Philly     Duration: 00:24Published
Pfizer And BioNTech Says Its Covid-19 Vaccine Is 100% Effective And Well Tolerated In Children Ages 12 To 15 [Video]

Pfizer And BioNTech Says Its Covid-19 Vaccine Is 100% Effective And Well Tolerated In Children Ages 12 To 15

Clinical trial results of Pfizer/BioNTech's Covid-19 vaccine showed its efficacy is 100% and it is well tolerated in youths ages 12 to 15, the companies said Wednesday.

Credit: WJZ Baltimore     Duration: 00:36Published